Y-Intercept (HK)’s Lifestance Health LFST Stock Holding History

Y-Intercept (HK)’s Portfolio LFST Stock Details LFST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-54,807	Closed	-$283K	–	1821
2025 Q2	$283K	Sell	54,807 -31,839	-37%	-$191K	0.01%	1375
2025 Q1	$577K	Buy	+86,646	New	+$659K	0.04%	637

Other funds holding LFST

TGA

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Summit Partners Boston, Massachusetts $670M AUM 6.71% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Y-Intercept (HK)'s LFST Position: Q3 2025 in Review

Y-Intercept (HK) sold out of Lifestance Health (LFST) in Q3 2025, closing a stake of 54,807 shares — an estimated $283K sold.

Y-Intercept (HK) first reported a position in LFST in Q1 2025 and held it in 2 quarters. The position peaked at $577K in Q1 2025. 210 funds tracked by Wall St. Rank hold LFST as of Q3 2025.

Y-Intercept (HK) reported no remaining Lifestance Health position as of Q3 2025 after selling out during the quarter.
Y-Intercept (HK) sold 54,807 Lifestance Health shares in Q3 2025, an estimated $283K.
Y-Intercept (HK) first reported a position in Lifestance Health in Q1 2025 and held it in 2 quarters.
Y-Intercept (HK)'s Lifestance Health position peaked at $577K in Q1 2025.
210 funds tracked by Wall St. Rank held Lifestance Health as of Q3 2025.

Based on Y-Intercept (HK)'s 13F filing for Q3 2025, filed 31 Oct 2025.